Wellington J, et al. - Researchers created an algorithm (Algorithm 1) in which the number of axillary ultrasound (AUS)-suspicious nodes and tumor biology guide management in patients with T1–T2 breast cancer. They ascertained if routine AUS along with this algorithm could decrease axillary lymph node dissection (ALND) compared with a strategy of no preoperative AUS. As per findings, AUS use seemed to allow tailoring of patient care without overutilizing ALND, as long as neoadjuvant chemotherapy is administered when appropriate.